fbpx Skip to main content

Member's Profile

Lung Cancer Proteomics Dba TargetDx Laboratory

6541 Via Del Oro, Suite B
San Jose,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2018
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Lung Cancer Proteomics Dba TargetDx Laboratory
Biotech Company
Lung Cancer Proteomics has been doing research on developing a simple blood test that can detect early stage Non-Small Cell Lung Cancer (NSCLC) with high sensitivity and specificity since 2006. Our approach focuses on evaluating protein biomarkers in conjunction with proprietary algorithms and patient demographic information to provide a risk assessment for early stage lung cancer. We chose protein markers as it reflects information on the physiological condition of the tissue as a result of interaction between the genotype and the environment. Over the years, our company have discovered novel markers that may be related to lung cancer or have validated known markers with potential for diagnostic use in lung cancer. These discoveries have led to multiple patents and publications. Our CLIA laboratory has also expanded our menu to do COVID19 viral and antibody test and CRO services.
Related News
No related news posted by this Member